Nimit Impex Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -46.49%
- Profit Growth -81.46%
- Ebitda 12.18%
- Net Worth 45.37%
- Total Assets 4.52%
About Nimit Impex
Nimit Impex Private Limited (NIPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 April 2010 and has a history of 14 years and ten months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Ghatalia and Nimit Ghatalia serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74120MH2010PTC202203
- Company No.
202203
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Nimit Impex?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nimit Ghatalia  | Director | 05-Apr-2019 | Current |
| Rajesh Ghatalia | Director | 20-Apr-2010 | Current |
Financial Performance of Nimit Impex.
Nimit Impex Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 46.49% decrease. The company also saw a substantial fall in profitability, with a 81.46% decrease in profit. The company's net worth Soared by an impressive increase of 45.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nimit Impex?
Unlock access to Nimit Impex's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Aarey Drugs And Pharmaceuticals LimitedNimit Ghatalia is a mutual person
Worth Investment & Trading Co LtdNimit Ghatalia is a mutual person
Suraj Tradelinks Private LimitedRajesh Ghatalia and Nimit Ghatalia are mutual person
- Shalimar Chemical Industries Private Limited
Rajesh Ghatalia is a mutual person
- Designs By The Bay Llp
Nimit Ghatalia is a mutual person
- Enam Organics India Limited
Nimit Ghatalia is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nimit Impex?
Unlock and access historical data on people associated with Nimit Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nimit Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nimit Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
